Latest Penn Medicine News

July 25, 2016

Personalized Medicine Meets Thyroid Cancer: Drug Targeting BRAF Mutation Helps Patients

Vemurafenib Elicits a Response in a Third of Advanced Thyroid Cancer Patients with the BRAFV600E Mutation, Penn Study Finds

In the era of precision medicine, targeting the mutations driving cancer growth, rather than the tumor site itself, continues to be a successful approach for some patients. In the latest example, researchers from Penn Medicine and other institutions found that treating metastatic thyroid cancer patients harboring a BRAF mutation with the targeted therapy vemurafenib —originally approved for melanoma patients with the mutation—showed promising anti-tumor activity in a third of patients.  Read more ...

Penn Medicine News Blog

July 25, 2016

Students Are Her Business

Imagine almost any official function that involves Penn's medical students -- for example, the White Coat Ceremony, Match Day, or Graduation -- and the odds are excellent that Barbara Wagner would be there. Not as the speaker or guest of honor, but as director of the Student Affairs office. Wagner would be helping to keep things running smoothly. Or she might be the person being hugged by a grateful student she has helped along the way. Read more ...

Media Resources

Receive Penn Medicine News Updates via Email

Recent News Releases

July 20, 2016

July 19, 2016

July 20, 2016

July 19, 2016

July 18, 2016

July 15, 2016

July 14, 2016

The Nation's First Medical School Turns 250

Penn Medicine Magazine

Summer 2016

Current Issue: Summer 2016

Focus on Precision Medicine

Combine the wealth of health-related information now available to doctors and researchers with the substantial advances in molecular biology, and the result is the remarkable growth of precision medicine. The goal: to provide the right treatment to each individual at the right time.

View digital version online

Penn Medicine In the News